FT012
Chronic kidney disease
PreclinicalActive
Key Facts
About Certa Therapeutics
Australian precision‑medicine biotech targeting fibrosis through GPR68 inhibition.
View full company profileTherapeutic Areas
Other Chronic kidney disease Drugs
| Drug | Company | Phase |
|---|---|---|
| Renadyl | Centaur Pharmaceuticals | Phase 2 |
| BASH-001 | Bash Biotech | Preclinical |
| XGal-3® Apheresis Column | Eliaz Therapeutics | Research |
| Undisclosed CKD Program | Averoa | Pre-clinical |
| Platform Application - CKD | MultiOmic Health | Discovery |